Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Cancer Research and Clinical Oncology|July 19, 2023
Establishment of a prognostic model based on m<sup>6</sup>A regulatory factors and stemness of hepatocellular carcinoma using RNA-seq data and scRNA-seq dataYan Liang, Sen Chen, Jinghe Xie, et al.
Frontiers in Cell and Developmental Biology|January 3, 2022
ITGB1 Drives Hepatocellular Carcinoma Progression by Modulating Cell Cycle Process Through PXN/YWHAZ/AKT PathwaysJinghe Xie, Tingting Guo, Zhiyong Zhong, et al.
Nature Biotechnology|May 29, 2019
A coiled-coil masking domain for selective activation of therapeutic antibodiesVivian H Trang, Xinqun Zhang, Roma C Yumul, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2013
Development of orally active inhibitors of protein and cellular fucosylationNicole M Okeley, Stephen C Alley, Martha E Anderson, et al.
Molecular Cancer Therapeutics|March 6, 2016
Development of Novel Quaternary Ammonium Linkers for Antibody-Drug ConjugatesPatrick J Burke, Joseph Z Hamilton, Thomas A Pires, et al.
Bioconjugate Chemistry|May 24, 2024
Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune ActivationPhilip N Moquist, Xinqun Zhang, Chris I Leiske, et al.
Molecular Cancer Therapeutics|October 29, 2025
Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical modelsDavid R Gruber, Elizabeth J Cummins, Weiping Zeng, et al.
Molecular Cancer Therapeutics|September 23, 2018
Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody-Drug ConjugatesChristopher S Neumann, Kathleen C Olivas, Martha E Anderson, et al.
Blood|June 18, 2013
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AMLMay S Kung Sutherland, Roland B Walter, Scott C Jeffrey, et al.
Molecular Cancer Therapeutics|November 17, 2017
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid LeukemiaFu Li, May Kung Sutherland, Changpu Yu, et al.
Pageof 5